CLDI
Calidi Biotherapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.32
-0.01 ▼ -3.78%
🌙 3월 13일 7:57 PM ET (한국 3/14 08:57)
$0.32
+0.00 +0.57%
| Index | - | P/E | - | EPS (ttm) | -8.77 | Insider Own | 25.33% | Shs Outstand | 0.01B | Perf Week | -11.81% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | -0.05% | Shs Float | 0.01B | Perf Month | -61.03% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | - | Inst Own | 6.07% | Short Float | 1.06% | Perf Quarter | -78.79% |
| Income | -0.03B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.32 | Perf Half Y | -80.48% |
| Sales | 0.00B | P/B | 0.32 | EPS next 5Y | - | ROA | -247.7% | Short Interest | 0.06M | Perf YTD | -72.81% |
| Book/sh | 1 | P/C | 0.22 | EPS past 3/5Y | - | ROE | - | 52W High | -98.34% ($19.20) | Perf Year | -96.59% |
| Cash/sh | 1.42 | P/FCF | - | Sales past 3/5Y | - | ROIC | -306.64% | 52W Low | -1.09% ($0.32) | Perf 3Y | -99.97% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 87.42% | Gross Margin | - | Volatility(W/M) | 6.28% 9.22% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.08 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.12 | EPS Q/Q | -184.49% | Profit Margin | - | RSI (14) | 17.86 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.12 | Sales Q/Q | - | SMA20 | -50.94% ($0.65) | Beta | 1.28 | Target Price | $120 |
| Payout | - | Debt/Eq | 0.48 | Earnings | 11000000 | SMA50 | -63.5% ($0.88) | Rel Volume | 1.18 | Prev Close | $0.33 |
| Employees | 28 | LT Debt/Eq | 0.21 | EPS/Sales Surpr. | -31.55% - | SMA200 | -87.16% ($2.49) | Avg Volume(3M) | 0.18M | Price | $0.32 |
| IPO | 2021/11/1 | Option/Short | No/Yes | Trades | 323 | Volume | 216,329 | Change | -3.78% |
뉴스 로딩 중...